Beta-carotene exerted anti-proliferative and apoptotic effect on malignant mesothelioma cells

Naunyn Schmiedebergs Arch Pharmacol. 2022 Apr;395(4):407-415. doi: 10.1007/s00210-022-02214-6. Epub 2022 Feb 2.

Abstract

High blood levels of β-carotene and increased intake in the diets are inversely proportional to incidence of many cancer types. Antioxidant activity of β-carotene was proposed to be related with its antitumor effect. Despite this plant derivative substance being sought in many cancer types, the effectiveness of β-carotene against malignant mesothelioma remained unclear. Therefore, the present study aims to explore the impact of β-carotene on cell viability, apoptosis, and oxidative stress in mesothelioma cells. Human mesothelioma cell SPC212 were treated with β-carotene (3.125-200 μM) for 24, 48, 72, and 96 h. Cytotoxicity was measured with the MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide). Annexin-V/propidium iodide (PI) and caspase 3/7 biomarkers were used to identify apoptotic cells. Finally, the oxidative stress was evaluated with flow cytometry. The results of the measurements indicated a significant decline in viable mesothelioma cancer cell numbers upon β-carotene treatment in time- and concentration-dependent manner when compared to control cells. Furthermore, β-carotene treatment led to apoptosis induction according to both annexin V/PI and caspase 3/7 assays. Furthermore, β-carotene increased oxidative stress in SPC212 cells. These results show how β-carotene affects proliferative, apoptotic, and oxidative properties in SPC212 malignant pleural mesothelioma cells and provide useful insights into future studies.

Keywords: Apoptosis; Cytotoxicity; Malignant pleural mesothelioma; SPC212; β-Carotene.

MeSH terms

  • Apoptosis
  • Cell Count
  • Cell Line, Tumor
  • Humans
  • Mesothelioma* / drug therapy
  • Mesothelioma, Malignant*
  • beta Carotene / pharmacology

Substances

  • beta Carotene